BPH Global Ltd (BP8) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.413x

Based on the latest financial reports, BPH Global Ltd (BP8) has a cash flow conversion efficiency ratio of 0.413x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-604.18K ≈ $-427.50K USD) by net assets (AU$-1.46 Million ≈ $-1.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of BPH Global Ltd to measure how much of total assets are equity-financed.

BPH Global Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how BPH Global Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BP8 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

BPH Global Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BPH Global Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Weaccess Group SA
PA:MLWEA
0.230x
PreveCeutical Medical Inc
F:18H
0.070x
Agereh Technologies Inc
V:AUTO
0.039x
REDSUN PROPERTIES GROUP
F:0RJ
N/A
Kuniko Ltd
AU:KNI
-0.069x
On The Beach Group PLC
LSE:OTB
0.335x
Meiwu Technology Co Ltd
NASDAQ:WNW
0.047x
Genesis Resources Ltd
AU:GES
-0.764x

Annual Cash Flow Conversion Efficiency for BPH Global Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of BPH Global Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see BPH Global Ltd stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-1.46 Million
≈ $-1.04 Million
AU$-929.81K
≈ $-657.90K
0.635x +143.22%
2023-06-30 AU$911.90K
≈ $645.22K
AU$-1.34 Million
≈ $-947.87K
-1.469x -164.66%
2022-06-30 AU$4.72 Million
≈ $3.34 Million
AU$-2.62 Million
≈ $-1.85 Million
-0.555x -167.29%
2021-06-30 AU$6.48 Million
≈ $4.58 Million
AU$-1.35 Million
≈ $-951.69K
-0.208x +87.69%
2020-06-30 AU$760.03K
≈ $537.77K
AU$-1.28 Million
≈ $-907.30K
-1.687x -295.36%
2019-06-30 AU$2.08 Million
≈ $1.47 Million
AU$-888.26K
≈ $-628.50K
-0.427x +67.16%
2018-06-30 AU$1.20 Million
≈ $849.55K
AU$-1.56 Million
≈ $-1.10 Million
-1.299x -650.01%
2017-06-30 AU$2.12 Million
≈ $1.50 Million
AU$-368.03K
≈ $-260.40K
-0.173x +25.38%
2016-06-30 AU$4.15 Million
≈ $2.94 Million
AU$-964.59K
≈ $-682.51K
-0.232x +94.32%
2015-06-30 AU$149.84K
≈ $106.02K
AU$-612.90K
≈ $-433.66K
-4.090x -4763.73%
2007-06-30 AU$67.97 Million
≈ $48.09 Million
AU$-5.72 Million
≈ $-4.04 Million
-0.084x -121.86%
2006-06-30 AU$67.48 Million
≈ $47.75 Million
AU$25.96 Million
≈ $18.37 Million
0.385x -14.36%
2004-06-30 AU$17.95 Million
≈ $12.70 Million
AU$8.06 Million
≈ $5.70 Million
0.449x -57.18%
2003-06-30 AU$12.64 Million
≈ $8.94 Million
AU$13.26 Million
≈ $9.38 Million
1.049x +1049.89%
2001-06-30 AU$11.29 Million
≈ $7.99 Million
AU$1.03 Million
≈ $728.79K
0.091x --

About BPH Global Ltd

AU:BP8 Australia Drug Manufacturers - Specialty & Generic
Market Cap
$3.33 Million
AU$4.71 Million AUD
Market Cap Rank
#29263 Global
#1637 in Australia
Share Price
AU$0.00
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.00
All Time High
AU$2.05
About

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics… Read more